VXX News Alert VIX Short-Term Futures ETN Ipath (VXX) 28.10 11/18/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
VIX Short-Term Futures ETN Ipath (VXX) 28.10 $VXX

Look for Shares of iPATH S&P 500 VIX Short-Term Futures ETN to Potentially Rebound after Yesterday's 1.75% Sell Off
Comtex SmarTrend(R) - Tue Nov 18, 3:48PM CST
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $27.73 to a high of $28.43. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of $27.99 on volume of 24.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
VXX: 28.10 (-0.50)

SmarTrend Watching for Potential Rebound in Shares of iPATH S&P 500 VIX Short-Term Futures ETN After 1.75% Loss
Comtex SmarTrend(R) - Tue Nov 18, 3:47PM CST
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $27.73 to a high of $28.43. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of $27.99 on volume of 24.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
VXX: 28.10 (-0.50)

The Curious Case Of Elevated Volatility (Weight Of Evidence, Part 2 Of 7)
360 Investment Research - at Seeking Alpha - Tue Nov 18, 2:33PM CST
"Fear tends to manifest itself much quicker than greed, so volatile markets tend to be on the downside. In up markets, volatility tends to gradually decline." ~ Philip Roth The CBOE Volatility Index is often referred to as the FEAR Index....
TVIX: 2.46 (-0.06), VXX: 28.10 (-0.50), IVOP: 38.18 (+0.07), UVXY: 21.38 (-0.85), VIIX: 37.96 (-0.73), XXV: 38.36 (-0.02), VIXY: 18.66 (-0.35), SVXY: 73.96 (+1.36), XIV: 37.66 (+0.62)

Why I'm Done Shorting Volatility For Now
Josh Arnold - at Seeking Alpha - Tue Nov 18, 3:21AM CST

VXX: 28.10 (-0.50), SVXY: 73.96 (+1.36)

U.S. Stocks Are the Top Investment as Japan Slips Into Recession
at The Street - Mon Nov 17, 1:38PM CST
The CNBC 'Fast Money' trading panel deemed U.S. equities as the better choice over international plays. Plus, should investors steer clear of General Motors or buy the pullback?
TSLA: 257.70 (+3.72), GPRO: 84.10 (+2.60), F: 15.50 (-0.04), VXX: 28.10 (-0.50), TLT: 119.52 (+0.33), ITW: 94.71 (+0.73), SJM: 101.97 (+0.45), YHOO: 51.75 (-0.62), SPY: 205.55 (+1.18), QQQ: 103.68 (+0.77), DIA: 176.96 (+0.47), GM: 32.27 (-0.04), IWM: 116.39 (+0.67), AAPL: 115.47 (+1.48), MBLY: 47.33 (+0.35), BABA: 110.81 (-3.44)

Hot Potato: Playing Chicken With The VIX
Force Majeure - at Seeking Alpha - Mon Nov 17, 10:18AM CST

TVIX: 2.46 (-0.06), SPY: 205.55 (+1.18), QQQ: 103.68 (+0.77), VXX: 28.10 (-0.50), XIV: 37.66 (+0.62)

Market Outlook - Small But Growing Reasons To Be Concerned Here
Price Headley, CFA - Seeking Alpha - Mon Nov 17, 6:15AM CST
Stocks may have technically made a fourth straight weekly gain last week, but the real story was the incredibly quiet, flat market action. We'll delve into overall stock market index analysis, and some factors that have us concerned despite the...
SPY: 205.55 (+1.18), QQQ: 103.68 (+0.77), VXX: 28.10 (-0.50), DIA: 176.96 (+0.47), IWM: 116.39 (+0.67)

iPATH S&P 500 VIX Short-Term Futures ETN Has Returned 14.7% Since SmarTrend Recommendation (VXX)
Comtex SmarTrend(R) - Fri Nov 14, 9:20AM CST
SmarTrend identified a Downtrend for iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) on October 21st, 2014 at $33.67. In approximately 3 weeks, iPATH S&P 500 VIX Short-Term Futures ETN has returned 14.73% as of today's recent price of $28.71.
VXX: 28.10 (-0.50)

SmarTrend Watching for Potential Rebound in Shares of iPATH S&P 500 VIX Short-Term Futures ETN After 3.93% Loss
Comtex SmarTrend(R) - Mon Nov 10, 3:41PM CST
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $27.70 to a high of $28.96. Yesterday, the shares fell 3.9%, which took the trading range below the 3-day low of $28.96 on volume of 29.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
VXX: 28.10 (-0.50)

Watch for iPATH S&P 500 VIX Short-Term Futures ETN to Potentially Rebound After Falling 3.93% Yesterday
Comtex SmarTrend(R) - Mon Nov 10, 3:41PM CST
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $27.70 to a high of $28.96. Yesterday, the shares fell 3.9%, which took the trading range below the 3-day low of $28.96 on volume of 29.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
VXX: 28.10 (-0.50)

Market Outlook - Where We Stand Now After The Volatility
Price Headley, CFA - Seeking Alpha - Mon Nov 10, 1:38AM CST
It wasn't an especially stellar week for the market, but a gain is a gain. Even a small gain is better than a loss, right? Yet, it still seems as if the rally is running out of steam, with investors hesitant to keep pouring in when the market is this...
SPY: 205.55 (+1.18), QQQ: 103.68 (+0.77), VXX: 28.10 (-0.50), DIA: 176.96 (+0.47), IWM: 116.39 (+0.67)

12.4% Return Seen to Date on SmarTrend iPATH S&P 500 VIX Short-Term Futures ETN Call (VXX)
Comtex SmarTrend(R) - Fri Nov 07, 9:31AM CST
SmarTrend identified a Downtrend for iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) on October 21st, 2014 at $33.67. In approximately 2 weeks, iPATH S&P 500 VIX Short-Term Futures ETN has returned 12.44% as of today's recent price of $29.48.
VXX: 28.10 (-0.50)

Watch for iPATH S&P 500 VIX Short-Term Futures ETN to Potentially Rebound After Falling 1.24% Yesterday
Comtex SmarTrend(R) - Wed Nov 05, 3:48PM CST
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $30.01 to a high of $30.79. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $30.10 on volume of 25.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
VXX: 28.10 (-0.50)

iPATH S&P 500 VIX Short-Term Futures ETN Set to Possibly Rebound After Yesterday's Selloff of 1.24%
Comtex SmarTrend(R) - Wed Nov 05, 3:47PM CST
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $30.01 to a high of $30.79. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $30.10 on volume of 25.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
VXX: 28.10 (-0.50)

BOJ Marks The Beginning Of The End For Central Banks
Harold L. Vogel, CFA - at Seeking Alpha - Wed Nov 05, 12:24PM CST

VXX: 28.10 (-0.50), TBT: 52.40 (-0.24)

Overcrowded Trade Du Jour: Short Volatility
Jesse Felder - Seeking Alpha - Tue Nov 04, 2:50PM CST
Periods of low volatility are to investors what a sweet lullaby sung by whispering nanny is to an overtired baby. It relaxes them, gets them to put their worries aside and believe that everything is going to be okay. Great for babies. Not so great...
TVIX: 2.46 (-0.06), VXX: 28.10 (-0.50), IVOP: 38.18 (+0.07), UVXY: 21.38 (-0.85), VIIX: 37.96 (-0.73), XXV: 38.36 (-0.02), VIXY: 18.66 (-0.35), SVXY: 73.96 (+1.36), XIV: 37.66 (+0.62)

The VIX And Seasonality: Long Live Santa Claus And The Turkey Gods
Force Majeure - Seeking Alpha - Mon Nov 03, 11:35AM CST
The month of October has certainly been a wild one for U.S. markets with the second half of the month the polar opposite of the first. The first two weeks were dominated by fear regarding global growth, ebola, and geopolitical instability and...
TVIZ: 19.85 (-0.01), TVIX: 2.46 (-0.06), SPY: 205.55 (+1.18), QQQ: 103.68 (+0.77), VXX: 28.10 (-0.50), UVXY: 21.38 (-0.85), VXZ: 12.33 (+0.01), XIV: 37.66 (+0.62)

Market Outlook - Biggest 2 Week Gain Since 2009
Price Headley, CFA - Seeking Alpha - Mon Nov 03, 3:49AM CST
Three weeks ago, the market was on the brink of turning a minor pullback into a major meltdown. In the two weeks since then, the market has done something it hasn't done in years (since 2009, see further below in the article). What's that? Log a 7%...
SPY: 205.55 (+1.18), QQQ: 103.68 (+0.77), VXX: 28.10 (-0.50), DIA: 176.96 (+0.47), IWM: 116.39 (+0.67)

Shorting VXX And Sleep: How To Do Both
Thomas Novak - at Seeking Alpha - Sun Nov 02, 12:00PM CST

VXX: 28.10 (-0.50)

Weekly ETF Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 3:17PM CDT

IJS: 115.02 (+0.51), IWC: 73.51 (+0.42), GDXJ: 29.36 (+1.86), VXX: 28.10 (-0.50), SIVR: 15.99 (+0.06), GAZ: 2.65 (+0.01), SLV: 15.55 (+0.05), IWM: 116.39 (+0.67), GDX: 20.30 (+0.91), EWJ: 11.74 (+0.16)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 136

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 218

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 337

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 288

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 201

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 531

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 161

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 97

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
D-Wave Investors Must Decide by Dec 15 Class Suit

Updated Category News Views 117

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 206

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover the Enhanced Features of the New ONYX RX32 Scrubber

Updated Category News Views 116

Introducing the New RX32 Ride-On Floor Scrubber Optimal Performance for Large-Area Cleaning In response to the growing need for effective cleaning solutions, ONYX Systems, LLC launches the advanced RX32 Ride-On Floor Scrubber. This 32-inch scrubber is designed specifically to enhance cleaning efficiency and productivity in large facilities. Unmatched Cleaning Power The...

Continue Reading
Deckers Outdoor Achieves Record Stock Price Amid Growth

Updated Category News Views 253

Deckers Outdoor Corporation Reaches New Stock Milestone Deckers Outdoor Corporation (NYSE: DECK), known for its exceptional footwear and apparel offerings, has achieved a remarkable milestone as its stock price climbs to an all-time high of $213.03. This impressive rise is indicative of the company's strong financial health and robust market performance. With a...

Continue Reading
Remarkable Growth in Badger Meter's Financial Performance

Updated Category News Views 76

Badger Meter's Impressive Q3 2024 Financial Results Badger Meter, Inc. (NYSE: BMI) has recently reported its remarkable financial outcomes for the third quarter that ended on September 30, 2024. The company has recorded impressive growth across its various financial metrics, indicating strong market demand and operational excellence. Key Highlights of Q3 2024 The latest...

Continue Reading
Perion Network's Collaboration with Experian Boosts Ad Targeting

Updated Category News Views 242

Perion Network Partners with Experian to Enhance Ad Solutions Perion Network (NASDAQ: PERI), a leading figure in the digital advertising technology sector, is taking a significant step forward with its collaboration with Experian, a renowned global data and analytics company. This strategic partnership aims to enhance Perion's advertising capabilities, focusing on...

Continue Reading
Novo Nordisk Investors Seek Class Action Guidance Following Lawsuit

Updated Category News Views 213

Insights into the Novo Nordisk Class Action Lawsuit Recent news has surfaced regarding Novo Nordisk A/S (NYSE: NVO), a major player in the global pharmaceutical industry, which is making headlines following the announcement of a class action lawsuit. This legal action is spearheaded by Berger Montague, a notable law firm based in various cities across the United States,...

Continue Reading